Biotech news

Reset all filters
Geography
Company
Refine search
EPO expects unitary patent ratification despite ‘Brexit’
Pharma
The European Patent Office has said that it expects a solution will be found to allow the implementation of the unitary patent despite the referendum result.   24 June 2016
Life Sciences Law Forum 2016: The practicalities of litigating disputes
Pharma
The practicalities of litigating disputes were discussed yesterday in the session “Collaboration agreements – What are the best jurisdictions to resolve disputes” at the Life Sciences Law Forum 2016 in London.   24 June 2016
US Supreme Court set to consider Ariosa v Sequenom
Americas
The US Supreme Court is set to consider today whether to take on a long running patent dispute between Sequenom and Ariosa Diagnostics centring on pre-natal testing.   23 June 2016
Pharma
While pharmaceutical companies are more likely to seek patent protection for their inventions, trade secrets can be useful too, particularly following two recent legislative developments, say Andy Sanderson and Ling Zhuang of Potter Clarkson.   23 June 2016
Americas
A US advisory panel has reportedly approved the use of the CRISPR/Cas9 gene-editing technology on humans for the first time, as part of a study designed to target three types of cancer.   22 June 2016
Americas
The US Supreme Court has invited the solicitor general to file briefs in the Amgen v Sandoz biosimilars case in order to obtain the Obama administration’s view on the dispute between the two companies.   22 June 2016
Americas
The Canadian Intellectual Property Office has updated its guidelines on procedural and examination practices, with some changes affecting biotechnology and medicinal inventions, explain Jason Markwell and Stephanie Anderson of Belmore Neidrauer.   22 June 2016
Americas
Japan-based pharmaceutical company Daiichi Sankyo has secured victory in an inter partes review against Canada-based Alethia Biotherapeutics.   20 June 2016
Americas
Business law firm Procopio has added Robert Ramos as a partner in its life sciences practice group in San Diego.   20 June 2016
Asia
In a recent decision in India, biopharma company Biocon and its partner Mylan were allowed to continue marketing a biosimilar breast cancer drug, as Vikrant Rana and Sanjeeta Das of SS Rana report.   16 June 2016